| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Water | 47 | 2017 | 1410 | 3.190 |
Why?
|
| Urinary Bladder | 41 | 2024 | 1152 | 3.120 |
Why?
|
| Aquaporins | 27 | 2021 | 174 | 2.850 |
Why?
|
| Cell Membrane Permeability | 40 | 2012 | 573 | 2.630 |
Why?
|
| Urination | 8 | 2019 | 203 | 2.270 |
Why?
|
| Kidney Medulla | 25 | 2017 | 169 | 1.890 |
Why?
|
| Kidney Tubules, Collecting | 24 | 2014 | 162 | 1.750 |
Why?
|
| Water-Electrolyte Balance | 8 | 2017 | 325 | 1.520 |
Why?
|
| Urea | 20 | 2017 | 442 | 1.450 |
Why?
|
| Urothelium | 13 | 2016 | 269 | 1.330 |
Why?
|
| Lipid Bilayers | 16 | 2012 | 379 | 1.200 |
Why?
|
| Cell Membrane | 30 | 2014 | 3665 | 1.200 |
Why?
|
| Squalus acanthias | 2 | 2021 | 5 | 1.050 |
Why?
|
| Cystitis | 8 | 2020 | 95 | 0.970 |
Why?
|
| Fish Proteins | 3 | 2021 | 47 | 0.950 |
Why?
|
| Atrial Natriuretic Factor | 13 | 1996 | 350 | 0.940 |
Why?
|
| Kidney Tubules | 17 | 1998 | 448 | 0.930 |
Why?
|
| Equipment and Supplies | 2 | 2020 | 273 | 0.890 |
Why?
|
| Permeability | 33 | 2016 | 721 | 0.850 |
Why?
|
| Urodynamics | 5 | 2021 | 346 | 0.840 |
Why?
|
| Liposomes | 14 | 2007 | 783 | 0.820 |
Why?
|
| Sodium | 16 | 2014 | 1589 | 0.820 |
Why?
|
| Ion Channels | 16 | 2003 | 1039 | 0.800 |
Why?
|
| Vasopressins | 11 | 2014 | 351 | 0.750 |
Why?
|
| Protons | 13 | 2006 | 1112 | 0.740 |
Why?
|
| Acid-Base Equilibrium | 2 | 2018 | 181 | 0.690 |
Why?
|
| Kidney | 20 | 2020 | 7034 | 0.650 |
Why?
|
| Biological Transport | 33 | 2012 | 2082 | 0.640 |
Why?
|
| Acid-Base Imbalance | 2 | 2018 | 41 | 0.640 |
Why?
|
| Ammonia | 11 | 2005 | 243 | 0.600 |
Why?
|
| Health Care Sector | 1 | 2020 | 195 | 0.600 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2018 | 21 | 0.600 |
Why?
|
| Mesencephalon | 1 | 2019 | 332 | 0.570 |
Why?
|
| Reflex | 1 | 2019 | 375 | 0.570 |
Why?
|
| International Educational Exchange | 1 | 2017 | 49 | 0.550 |
Why?
|
| Foreign Medical Graduates | 1 | 2017 | 77 | 0.530 |
Why?
|
| Annexin A4 | 2 | 2008 | 9 | 0.530 |
Why?
|
| Glomerular Filtration Rate | 4 | 2014 | 2181 | 0.520 |
Why?
|
| Animals | 130 | 2024 | 168083 | 0.510 |
Why?
|
| Academic Medical Centers | 5 | 2014 | 2757 | 0.490 |
Why?
|
| Oocytes | 8 | 2020 | 1165 | 0.480 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2017 | 292 | 0.480 |
Why?
|
| Aquaporin 1 | 16 | 2008 | 57 | 0.470 |
Why?
|
| Erythrocyte Membrane | 8 | 2011 | 438 | 0.470 |
Why?
|
| Internal Medicine | 3 | 2017 | 1051 | 0.470 |
Why?
|
| Gills | 3 | 2021 | 21 | 0.460 |
Why?
|
| Cell Polarity | 5 | 2014 | 638 | 0.460 |
Why?
|
| Hypothalamus | 1 | 2019 | 999 | 0.460 |
Why?
|
| Emigration and Immigration | 1 | 2017 | 397 | 0.450 |
Why?
|
| Homeostasis | 3 | 2014 | 3318 | 0.450 |
Why?
|
| Mechanical Phenomena | 1 | 2014 | 142 | 0.430 |
Why?
|
| Hydrogen-Ion Concentration | 19 | 2018 | 2478 | 0.420 |
Why?
|
| Nephrons | 1 | 2014 | 168 | 0.420 |
Why?
|
| Physiology, Comparative | 1 | 2012 | 8 | 0.410 |
Why?
|
| Hagfishes | 1 | 2012 | 12 | 0.400 |
Why?
|
| Hospital-Patient Relations | 1 | 2012 | 17 | 0.400 |
Why?
|
| tau Proteins | 3 | 2021 | 2094 | 0.400 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 12 | 2003 | 476 | 0.390 |
Why?
|
| Hyponatremia | 2 | 2014 | 279 | 0.390 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2014 | 540 | 0.370 |
Why?
|
| Endosomes | 4 | 2003 | 518 | 0.350 |
Why?
|
| Aerospace Medicine | 1 | 2011 | 95 | 0.350 |
Why?
|
| Protamines | 3 | 2014 | 112 | 0.350 |
Why?
|
| Rabbits | 25 | 2003 | 4749 | 0.340 |
Why?
|
| Osmosis | 8 | 2012 | 103 | 0.340 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2012 | 392 | 0.330 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2010 | 130 | 0.330 |
Why?
|
| Therapies, Investigational | 1 | 2010 | 111 | 0.330 |
Why?
|
| Renal Dialysis | 5 | 2020 | 1796 | 0.330 |
Why?
|
| Phosphatidylcholines | 9 | 2010 | 404 | 0.330 |
Why?
|
| Membranes, Artificial | 2 | 2008 | 366 | 0.330 |
Why?
|
| Internship and Residency | 4 | 2017 | 5879 | 0.320 |
Why?
|
| Membrane Lipids | 6 | 2006 | 251 | 0.310 |
Why?
|
| Membrane Transport Proteins | 3 | 2009 | 1033 | 0.300 |
Why?
|
| Carbon Dioxide | 6 | 2012 | 1148 | 0.300 |
Why?
|
| Aquaporin 3 | 2 | 2021 | 14 | 0.300 |
Why?
|
| Muscle Contraction | 5 | 2022 | 1200 | 0.300 |
Why?
|
| Kidney Failure, Chronic | 4 | 2009 | 2478 | 0.300 |
Why?
|
| Appointments and Schedules | 1 | 2012 | 442 | 0.300 |
Why?
|
| Microscopy, Electron | 15 | 2003 | 2562 | 0.270 |
Why?
|
| Membrane Proteins | 15 | 2002 | 7844 | 0.270 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2019 | 361 | 0.270 |
Why?
|
| Epithelium | 12 | 2005 | 1603 | 0.260 |
Why?
|
| Body Water | 6 | 1998 | 340 | 0.260 |
Why?
|
| Biological Evolution | 1 | 2012 | 1075 | 0.260 |
Why?
|
| Epithelial Cells | 8 | 2008 | 3666 | 0.260 |
Why?
|
| Mice | 29 | 2024 | 81324 | 0.250 |
Why?
|
| Salt Gland | 1 | 2005 | 5 | 0.250 |
Why?
|
| Muscle, Smooth | 5 | 2022 | 927 | 0.250 |
Why?
|
| Ion Pumps | 1 | 2005 | 15 | 0.250 |
Why?
|
| Intracellular Membranes | 7 | 2004 | 387 | 0.250 |
Why?
|
| Caveolae | 1 | 2005 | 54 | 0.240 |
Why?
|
| Heparin Antagonists | 2 | 2002 | 34 | 0.240 |
Why?
|
| Peritoneal Dialysis | 3 | 2002 | 159 | 0.240 |
Why?
|
| Membrane Fluidity | 3 | 2004 | 67 | 0.240 |
Why?
|
| Hospital Departments | 1 | 2005 | 134 | 0.240 |
Why?
|
| Cell Fractionation | 1 | 2005 | 247 | 0.240 |
Why?
|
| Emergencies | 1 | 2011 | 1217 | 0.230 |
Why?
|
| Dogfish | 1 | 2004 | 11 | 0.230 |
Why?
|
| Flounder | 1 | 2004 | 6 | 0.230 |
Why?
|
| Organelles | 4 | 1994 | 264 | 0.230 |
Why?
|
| Vimentin | 2 | 2012 | 255 | 0.230 |
Why?
|
| Physician's Role | 1 | 2011 | 916 | 0.230 |
Why?
|
| Government Regulation | 2 | 2020 | 524 | 0.230 |
Why?
|
| Frail Elderly | 1 | 2009 | 765 | 0.230 |
Why?
|
| Parietal Cells, Gastric | 2 | 1994 | 44 | 0.230 |
Why?
|
| Plant Proteins | 3 | 2009 | 374 | 0.220 |
Why?
|
| Rats | 25 | 2010 | 23713 | 0.220 |
Why?
|
| Hospitals, Teaching | 1 | 2008 | 1155 | 0.220 |
Why?
|
| Cystoscopy | 1 | 2003 | 131 | 0.220 |
Why?
|
| Ascomycota | 1 | 2024 | 81 | 0.220 |
Why?
|
| Neurons | 3 | 2019 | 9435 | 0.210 |
Why?
|
| Blood Group Antigens | 10 | 1998 | 183 | 0.210 |
Why?
|
| Urology | 1 | 2008 | 400 | 0.210 |
Why?
|
| 5'-Nucleotidase | 1 | 2024 | 161 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3094 | 0.200 |
Why?
|
| Temperature | 6 | 2019 | 2219 | 0.200 |
Why?
|
| Brain | 4 | 2021 | 27097 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3216 | 0.200 |
Why?
|
| Caloric Restriction | 1 | 2024 | 299 | 0.200 |
Why?
|
| Peptide Fragments | 5 | 2011 | 5103 | 0.190 |
Why?
|
| Dinoprostone | 4 | 1992 | 597 | 0.190 |
Why?
|
| Fluorescence | 2 | 2003 | 754 | 0.190 |
Why?
|
| Health | 1 | 2024 | 398 | 0.190 |
Why?
|
| Nephrology | 2 | 2016 | 263 | 0.190 |
Why?
|
| Osmolar Concentration | 8 | 2010 | 658 | 0.190 |
Why?
|
| Bufo marinus | 5 | 1993 | 32 | 0.190 |
Why?
|
| Archaea | 1 | 2001 | 59 | 0.180 |
Why?
|
| Ureteral Obstruction | 2 | 1993 | 293 | 0.180 |
Why?
|
| Health Care Costs | 3 | 2016 | 3238 | 0.180 |
Why?
|
| Kinetics | 18 | 2009 | 6312 | 0.180 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 18217 | 0.180 |
Why?
|
| Materials Management, Hospital | 1 | 2020 | 8 | 0.180 |
Why?
|
| Urinary Retention | 1 | 2021 | 106 | 0.170 |
Why?
|
| Dementia, Vascular | 1 | 2021 | 122 | 0.170 |
Why?
|
| Quality of Health Care | 3 | 2012 | 4319 | 0.170 |
Why?
|
| Glycerol | 6 | 2009 | 275 | 0.170 |
Why?
|
| Fellowships and Scholarships | 2 | 2008 | 1116 | 0.170 |
Why?
|
| Urinary Bladder, Overactive | 2 | 2019 | 115 | 0.170 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 2 | 2000 | 71 | 0.170 |
Why?
|
| Osmotic Pressure | 2 | 2014 | 137 | 0.170 |
Why?
|
| Pandemics | 1 | 2020 | 8663 | 0.170 |
Why?
|
| Cloning, Molecular | 5 | 2012 | 4168 | 0.170 |
Why?
|
| Fasting | 2 | 2024 | 1603 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 9 | 2019 | 22129 | 0.170 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2019 | 34 | 0.170 |
Why?
|
| Oxygen Consumption | 11 | 1993 | 1866 | 0.170 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 1999 | 26 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2010 | 8164 | 0.170 |
Why?
|
| Actinobacillus pleuropneumoniae | 2 | 2009 | 8 | 0.160 |
Why?
|
| Hospital Costs | 1 | 2005 | 947 | 0.160 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2019 | 115 | 0.160 |
Why?
|
| Receptors, Cholinergic | 2 | 2000 | 244 | 0.160 |
Why?
|
| Substance P | 1 | 2000 | 334 | 0.160 |
Why?
|
| Pons | 2 | 2017 | 240 | 0.160 |
Why?
|
| Natriuresis | 3 | 1995 | 105 | 0.150 |
Why?
|
| Proteolipids | 3 | 1999 | 113 | 0.150 |
Why?
|
| Sodium Channels | 4 | 2004 | 339 | 0.150 |
Why?
|
| Medicine | 2 | 2021 | 942 | 0.150 |
Why?
|
| Potassium | 6 | 2014 | 1309 | 0.140 |
Why?
|
| Microsomes | 2 | 1994 | 251 | 0.140 |
Why?
|
| Urination Disorders | 1 | 2018 | 238 | 0.140 |
Why?
|
| Mineralocorticoids | 1 | 2017 | 37 | 0.140 |
Why?
|
| Amiloride | 8 | 2003 | 116 | 0.140 |
Why?
|
| Xenopus | 7 | 2020 | 709 | 0.140 |
Why?
|
| Hospitalists | 1 | 2021 | 294 | 0.140 |
Why?
|
| Myasthenia Gravis | 2 | 2000 | 214 | 0.140 |
Why?
|
| Aquaporin 6 | 4 | 2003 | 44 | 0.140 |
Why?
|
| Urologic Diseases | 1 | 2019 | 247 | 0.140 |
Why?
|
| Kidney Tubules, Proximal | 5 | 1997 | 382 | 0.140 |
Why?
|
| Neurons, Afferent | 1 | 2019 | 498 | 0.140 |
Why?
|
| Ketamine | 2 | 2020 | 517 | 0.140 |
Why?
|
| Longevity | 1 | 2024 | 1064 | 0.140 |
Why?
|
| Escherichia coli | 3 | 2009 | 4205 | 0.140 |
Why?
|
| Loop of Henle | 5 | 2008 | 38 | 0.140 |
Why?
|
| Xenopus laevis | 4 | 2008 | 962 | 0.140 |
Why?
|
| Palliative Care | 2 | 2009 | 3593 | 0.130 |
Why?
|
| Erythrocytes | 5 | 2024 | 2413 | 0.130 |
Why?
|
| Mice, Knockout | 7 | 2024 | 14393 | 0.130 |
Why?
|
| Symporters | 1 | 1999 | 363 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2003 | 2223 | 0.130 |
Why?
|
| Islam | 1 | 2017 | 71 | 0.130 |
Why?
|
| Body Weight | 2 | 2024 | 4618 | 0.130 |
Why?
|
| Humans | 63 | 2024 | 761098 | 0.130 |
Why?
|
| Biological Transport, Active | 6 | 1993 | 323 | 0.130 |
Why?
|
| Aquaporin 2 | 4 | 2003 | 126 | 0.130 |
Why?
|
| Bacteriophage M13 | 1 | 1995 | 39 | 0.130 |
Why?
|
| Ascorbic Acid | 1 | 1999 | 654 | 0.130 |
Why?
|
| Cholesterol | 6 | 2009 | 2902 | 0.130 |
Why?
|
| Autoantigens | 2 | 2000 | 887 | 0.130 |
Why?
|
| Carrier Proteins | 7 | 1999 | 4933 | 0.130 |
Why?
|
| Urethane | 1 | 2015 | 36 | 0.130 |
Why?
|
| Diffusion | 6 | 2008 | 813 | 0.130 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 695 | 0.130 |
Why?
|
| Erythrocyte Deformability | 2 | 2011 | 55 | 0.130 |
Why?
|
| Biological Assay | 1 | 2018 | 623 | 0.120 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1996 | 201 | 0.120 |
Why?
|
| Cytoplasmic Granules | 1 | 1998 | 573 | 0.120 |
Why?
|
| Staff Development | 1 | 2017 | 227 | 0.120 |
Why?
|
| Anemia, Dyserythropoietic, Congenital | 1 | 1994 | 15 | 0.120 |
Why?
|
| Health Status Indicators | 1 | 2000 | 970 | 0.120 |
Why?
|
| Models, Biological | 13 | 2019 | 9455 | 0.120 |
Why?
|
| Genes, Immunoglobulin | 1 | 1995 | 285 | 0.120 |
Why?
|
| Education, Medical, Graduate | 2 | 2016 | 2372 | 0.120 |
Why?
|
| Embryonic and Fetal Development | 2 | 1994 | 420 | 0.120 |
Why?
|
| Proteins | 4 | 2014 | 5993 | 0.120 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2004 | 2667 | 0.120 |
Why?
|
| Thirst | 1 | 2014 | 42 | 0.120 |
Why?
|
| Cyclic AMP | 3 | 2002 | 1463 | 0.110 |
Why?
|
| Kidney Diseases | 2 | 2016 | 2092 | 0.110 |
Why?
|
| Diabetes Insipidus | 1 | 2014 | 144 | 0.110 |
Why?
|
| Curriculum | 3 | 2021 | 3739 | 0.110 |
Why?
|
| Bufonidae | 4 | 1993 | 12 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 698 | 0.110 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2011 | 2157 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 5 | 2003 | 944 | 0.110 |
Why?
|
| Sphingomyelins | 3 | 2009 | 105 | 0.110 |
Why?
|
| Interstitial Cells of Cajal | 1 | 2012 | 23 | 0.100 |
Why?
|
| Bicarbonates | 4 | 1990 | 292 | 0.100 |
Why?
|
| Immunoblotting | 4 | 2011 | 1644 | 0.100 |
Why?
|
| Gene Library | 1 | 1995 | 1055 | 0.100 |
Why?
|
| Acetamides | 3 | 2000 | 257 | 0.100 |
Why?
|
| Intestines | 1 | 2021 | 1908 | 0.100 |
Why?
|
| Species Specificity | 2 | 2014 | 2406 | 0.100 |
Why?
|
| Mucin-1 | 1 | 1997 | 537 | 0.100 |
Why?
|
| Faculty, Medical | 2 | 2021 | 1205 | 0.100 |
Why?
|
| Haloperidol | 1 | 2014 | 389 | 0.100 |
Why?
|
| Cell Size | 1 | 2014 | 625 | 0.100 |
Why?
|
| Fundulidae | 1 | 2012 | 12 | 0.100 |
Why?
|
| Sodium Compounds | 1 | 2012 | 35 | 0.100 |
Why?
|
| Mice, Inbred Strains | 2 | 2014 | 1761 | 0.100 |
Why?
|
| Autoantibodies | 3 | 2000 | 2117 | 0.100 |
Why?
|
| United States | 9 | 2020 | 72337 | 0.100 |
Why?
|
| Female | 41 | 2024 | 392458 | 0.100 |
Why?
|
| Arsenites | 1 | 2012 | 65 | 0.100 |
Why?
|
| Maine | 1 | 2012 | 146 | 0.100 |
Why?
|
| Interleukin-1 | 2 | 1995 | 1250 | 0.100 |
Why?
|
| Muscle Cells | 1 | 2012 | 195 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1661 | 0.100 |
Why?
|
| Guanylate Cyclase | 2 | 1990 | 205 | 0.100 |
Why?
|
| Dogs | 5 | 2012 | 3832 | 0.100 |
Why?
|
| Quality Assurance, Health Care | 1 | 2002 | 2165 | 0.100 |
Why?
|
| Chironomidae | 1 | 2011 | 2 | 0.090 |
Why?
|
| Ouabain | 7 | 1993 | 246 | 0.090 |
Why?
|
| Phenotype | 5 | 2019 | 16572 | 0.090 |
Why?
|
| Aviation | 1 | 2011 | 49 | 0.090 |
Why?
|
| Myofibroblasts | 1 | 2012 | 223 | 0.090 |
Why?
|
| Acute Kidney Injury | 2 | 2020 | 1923 | 0.090 |
Why?
|
| Kinins | 1 | 1990 | 14 | 0.090 |
Why?
|
| Protein Precursors | 1 | 1995 | 1132 | 0.090 |
Why?
|
| Complement C4b | 1 | 2011 | 125 | 0.090 |
Why?
|
| Phosphates | 1 | 2014 | 763 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2003 | 2923 | 0.090 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1992 | 436 | 0.090 |
Why?
|
| Populus | 1 | 2009 | 10 | 0.090 |
Why?
|
| Mandatory Reporting | 1 | 2011 | 123 | 0.090 |
Why?
|
| Freezing | 1 | 2011 | 311 | 0.090 |
Why?
|
| Anguilla | 1 | 2009 | 4 | 0.090 |
Why?
|
| Genetic Variation | 2 | 2024 | 6565 | 0.090 |
Why?
|
| Morphine | 1 | 2014 | 656 | 0.080 |
Why?
|
| Lysosomes | 2 | 2002 | 920 | 0.080 |
Why?
|
| Academies and Institutes | 1 | 2012 | 318 | 0.080 |
Why?
|
| Serum | 1 | 2011 | 208 | 0.080 |
Why?
|
| Career Choice | 1 | 2016 | 757 | 0.080 |
Why?
|
| Molecular Weight | 5 | 1998 | 2171 | 0.080 |
Why?
|
| Sensory Receptor Cells | 1 | 2014 | 508 | 0.080 |
Why?
|
| Dehydration | 1 | 2011 | 216 | 0.080 |
Why?
|
| Geriatrics | 1 | 2014 | 387 | 0.080 |
Why?
|
| Hormones | 1 | 1993 | 869 | 0.080 |
Why?
|
| Massachusetts | 2 | 2020 | 8836 | 0.080 |
Why?
|
| Federal Government | 1 | 2011 | 267 | 0.080 |
Why?
|
| Ethers | 1 | 2009 | 73 | 0.080 |
Why?
|
| Formamides | 2 | 1999 | 21 | 0.080 |
Why?
|
| TRPV Cation Channels | 1 | 2010 | 243 | 0.080 |
Why?
|
| Nystatin | 3 | 1998 | 22 | 0.080 |
Why?
|
| Cyclic GMP | 2 | 1987 | 395 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2020 | 23415 | 0.080 |
Why?
|
| Chlorides | 3 | 1990 | 657 | 0.080 |
Why?
|
| Receptors, Cell Surface | 4 | 1994 | 2802 | 0.080 |
Why?
|
| Telephone | 1 | 2012 | 625 | 0.080 |
Why?
|
| Hydrogen Sulfide | 1 | 2009 | 141 | 0.080 |
Why?
|
| Male | 26 | 2019 | 360675 | 0.080 |
Why?
|
| Recombinant Proteins | 6 | 2004 | 6507 | 0.080 |
Why?
|
| Adenosine Triphosphatases | 4 | 2012 | 833 | 0.070 |
Why?
|
| Membrane Potentials | 4 | 2004 | 1089 | 0.070 |
Why?
|
| Water Pollutants, Chemical | 1 | 2012 | 359 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 1 | 2009 | 427 | 0.070 |
Why?
|
| Mercuric Chloride | 3 | 2011 | 17 | 0.070 |
Why?
|
| Deuterium Oxide | 1 | 2007 | 34 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2017 | 2160 | 0.070 |
Why?
|
| Guinea Pigs | 2 | 2000 | 1309 | 0.070 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 1999 | 202 | 0.070 |
Why?
|
| Ovalbumin | 2 | 2000 | 671 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2000 | 3388 | 0.070 |
Why?
|
| Actins | 1 | 2014 | 2046 | 0.070 |
Why?
|
| Endocytosis | 4 | 2002 | 950 | 0.070 |
Why?
|
| Fluorometry | 1 | 2007 | 99 | 0.070 |
Why?
|
| Hydroxides | 1 | 2006 | 46 | 0.070 |
Why?
|
| Public Policy | 1 | 2011 | 557 | 0.070 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 5841 | 0.070 |
Why?
|
| Hypercapnia | 1 | 1988 | 261 | 0.070 |
Why?
|
| Proton-Translocating ATPases | 3 | 1994 | 112 | 0.070 |
Why?
|
| Structure-Activity Relationship | 5 | 2012 | 3060 | 0.070 |
Why?
|
| Lung | 1 | 2005 | 9979 | 0.070 |
Why?
|
| Salts | 1 | 2006 | 62 | 0.070 |
Why?
|
| Reference Values | 5 | 2003 | 4922 | 0.060 |
Why?
|
| Thermodynamics | 3 | 1998 | 590 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2017 | 2054 | 0.060 |
Why?
|
| Transfection | 2 | 2008 | 5750 | 0.060 |
Why?
|
| Ibuprofen | 3 | 1992 | 229 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 1996 | 1731 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2009 | 3838 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2006 | 205 | 0.060 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 3 | 1990 | 43 | 0.060 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2004 | 11 | 0.060 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2004 | 24 | 0.060 |
Why?
|
| Education, Medical | 1 | 2017 | 1725 | 0.060 |
Why?
|
| Financial Management, Hospital | 1 | 2005 | 70 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2011 | 989 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 3416 | 0.060 |
Why?
|
| Caveolins | 1 | 2005 | 102 | 0.060 |
Why?
|
| Porins | 1 | 2004 | 78 | 0.060 |
Why?
|
| Transport Vesicles | 1 | 2005 | 81 | 0.060 |
Why?
|
| Chlorpromazine | 1 | 2004 | 111 | 0.060 |
Why?
|
| Health Services Research | 1 | 2012 | 1807 | 0.060 |
Why?
|
| Detergents | 3 | 2009 | 235 | 0.060 |
Why?
|
| Adenosine Triphosphate | 4 | 2004 | 1987 | 0.060 |
Why?
|
| Anisotropy | 2 | 1999 | 1284 | 0.060 |
Why?
|
| Health Policy | 1 | 2016 | 2680 | 0.060 |
Why?
|
| Sulfhydryl Reagents | 2 | 1994 | 29 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 3 | 2000 | 9185 | 0.060 |
Why?
|
| Cholinergic Agents | 1 | 2024 | 96 | 0.060 |
Why?
|
| Health Expenditures | 1 | 2016 | 2363 | 0.060 |
Why?
|
| Specialization | 1 | 2008 | 778 | 0.060 |
Why?
|
| Mathematics | 3 | 1996 | 702 | 0.050 |
Why?
|
| Superoxide Dismutase | 2 | 2004 | 593 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2012 | 2487 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 1995 | 2243 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2005 | 255 | 0.050 |
Why?
|
| Solutions | 3 | 1999 | 410 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 1559 | 0.050 |
Why?
|
| Fluorescence Polarization | 1 | 2003 | 140 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2003 | 2468 | 0.050 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2022 | 37 | 0.050 |
Why?
|
| Furosemide | 4 | 1993 | 170 | 0.050 |
Why?
|
| Radiation-Protective Agents | 1 | 2002 | 88 | 0.050 |
Why?
|
| Endothelins | 2 | 1995 | 127 | 0.050 |
Why?
|
| Spectrin | 2 | 2011 | 170 | 0.050 |
Why?
|
| Gastric Mucosa | 2 | 1996 | 603 | 0.050 |
Why?
|
| Delirium | 1 | 2014 | 1667 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 3535 | 0.050 |
Why?
|
| Ion Channel Gating | 1 | 2004 | 429 | 0.050 |
Why?
|
| Cells, Cultured | 7 | 2019 | 18926 | 0.050 |
Why?
|
| Locus Coeruleus | 1 | 2024 | 230 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2011 | 2135 | 0.050 |
Why?
|
| Nursing Homes | 1 | 2009 | 1083 | 0.050 |
Why?
|
| Data Collection | 1 | 2011 | 3319 | 0.050 |
Why?
|
| Calcium | 3 | 2020 | 5720 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2017 | 3801 | 0.050 |
Why?
|
| Bilirubin | 2 | 1994 | 435 | 0.050 |
Why?
|
| Apyrase | 1 | 2004 | 373 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 1 | 2003 | 925 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 908 | 0.050 |
Why?
|
| Glycerophospholipids | 1 | 2000 | 39 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2024 | 857 | 0.040 |
Why?
|
| Rubidium Radioisotopes | 2 | 1991 | 97 | 0.040 |
Why?
|
| Exocytosis | 1 | 2002 | 320 | 0.040 |
Why?
|
| Fluorescent Dyes | 3 | 2000 | 1902 | 0.040 |
Why?
|
| snRNP Core Proteins | 2 | 2000 | 21 | 0.040 |
Why?
|
| Time Factors | 11 | 2018 | 39953 | 0.040 |
Why?
|
| Cat Diseases | 1 | 2000 | 31 | 0.040 |
Why?
|
| Ammonium Chloride | 2 | 1990 | 72 | 0.040 |
Why?
|
| Glycosphingolipids | 1 | 2000 | 73 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2008 | 3568 | 0.040 |
Why?
|
| Optics and Photonics | 1 | 2001 | 306 | 0.040 |
Why?
|
| Cystitis, Interstitial | 1 | 2000 | 66 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 2002 | 426 | 0.040 |
Why?
|
| Attitude of Health Personnel | 2 | 2012 | 3882 | 0.040 |
Why?
|
| Carbonic Anhydrases | 2 | 2012 | 107 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2002 | 324 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 8601 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4813 | 0.040 |
Why?
|
| Thermography | 1 | 2019 | 63 | 0.040 |
Why?
|
| Multigene Family | 2 | 2009 | 1075 | 0.040 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 2000 | 170 | 0.040 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2000 | 134 | 0.040 |
Why?
|
| Peptide Library | 1 | 2000 | 347 | 0.040 |
Why?
|
| Potassium Chloride | 2 | 1990 | 229 | 0.040 |
Why?
|
| Tomography | 1 | 2001 | 411 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 1664 | 0.040 |
Why?
|
| Calcitriol | 1 | 2001 | 295 | 0.040 |
Why?
|
| Octoxynol | 2 | 1996 | 76 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 3450 | 0.040 |
Why?
|
| Fluoresceins | 3 | 1994 | 235 | 0.040 |
Why?
|
| Meglumine | 2 | 1990 | 144 | 0.040 |
Why?
|
| Microsomes, Liver | 2 | 1996 | 172 | 0.040 |
Why?
|
| Potassium Cyanide | 2 | 1990 | 17 | 0.040 |
Why?
|
| Gramicidin | 2 | 2006 | 12 | 0.040 |
Why?
|
| Adenosine | 1 | 2024 | 805 | 0.040 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 11856 | 0.040 |
Why?
|
| Boston | 1 | 2012 | 9324 | 0.040 |
Why?
|
| Pennsylvania | 1 | 2000 | 612 | 0.040 |
Why?
|
| Calcium Channels, L-Type | 1 | 2020 | 242 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2014 | 10755 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2000 | 419 | 0.040 |
Why?
|
| Gases | 1 | 1999 | 204 | 0.040 |
Why?
|
| Accounts Payable and Receivable | 1 | 1998 | 11 | 0.040 |
Why?
|
| Radiation Injuries | 2 | 2004 | 1191 | 0.040 |
Why?
|
| Vacuoles | 1 | 1999 | 225 | 0.040 |
Why?
|
| Urinary Bladder Diseases | 1 | 2019 | 167 | 0.040 |
Why?
|
| Brain Stem | 1 | 2024 | 858 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2022 | 836 | 0.040 |
Why?
|
| Niacinamide | 1 | 2020 | 413 | 0.040 |
Why?
|
| Financing, Government | 1 | 2002 | 472 | 0.040 |
Why?
|
| Amphotericin B | 2 | 1990 | 142 | 0.040 |
Why?
|
| Swine | 4 | 2009 | 5909 | 0.040 |
Why?
|
| Hospital Records | 1 | 1998 | 93 | 0.040 |
Why?
|
| Cell Line | 6 | 2012 | 15542 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3925 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1990 | 2087 | 0.040 |
Why?
|
| Archaeal Proteins | 2 | 2009 | 58 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2024 | 2508 | 0.040 |
Why?
|
| Cell-Free System | 1 | 1998 | 336 | 0.040 |
Why?
|
| Peptides | 1 | 1989 | 4353 | 0.040 |
Why?
|
| Obesity | 1 | 2019 | 12937 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2000 | 646 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1998 | 525 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2000 | 1967 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 1990 | 4405 | 0.040 |
Why?
|
| Membrane Glycoproteins | 3 | 2002 | 3696 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 2005 | 17598 | 0.030 |
Why?
|
| Adiponectin | 1 | 2022 | 1106 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2024 | 2603 | 0.030 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 788 | 0.030 |
Why?
|
| Comorbidity | 2 | 2002 | 10514 | 0.030 |
Why?
|
| Amino Acid Sequence | 4 | 2005 | 13404 | 0.030 |
Why?
|
| Mitochondria | 3 | 2004 | 3620 | 0.030 |
Why?
|
| Kidney Glomerulus | 2 | 1990 | 567 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 5333 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2005 | 1711 | 0.030 |
Why?
|
| Advance Care Planning | 1 | 2003 | 683 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 2004 | 2262 | 0.030 |
Why?
|
| Chickens | 1 | 1998 | 857 | 0.030 |
Why?
|
| Bumetanide | 2 | 1993 | 98 | 0.030 |
Why?
|
| Cisplatin | 2 | 1993 | 1651 | 0.030 |
Why?
|
| Anesthetics, Dissociative | 1 | 2016 | 80 | 0.030 |
Why?
|
| Phosphorylation | 3 | 2017 | 8303 | 0.030 |
Why?
|
| Biotin | 2 | 1993 | 251 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2020 | 894 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2003 | 924 | 0.030 |
Why?
|
| Osmotic Fragility | 1 | 1994 | 35 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 1666 | 0.030 |
Why?
|
| Dissection | 1 | 1996 | 297 | 0.030 |
Why?
|
| Horseradish Peroxidase | 1 | 1994 | 166 | 0.030 |
Why?
|
| Carboxy-Lyases | 1 | 1974 | 85 | 0.030 |
Why?
|
| Adiposity | 1 | 2024 | 1879 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1996 | 864 | 0.030 |
Why?
|
| Models, Chemical | 2 | 2007 | 609 | 0.030 |
Why?
|
| Lipids | 3 | 2008 | 3330 | 0.030 |
Why?
|
| Freeze Fracturing | 1 | 1994 | 70 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2012 | 12743 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1994 | 141 | 0.030 |
Why?
|
| Smell | 1 | 2016 | 259 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2000 | 5033 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 5427 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1994 | 136 | 0.030 |
Why?
|
| Technology | 1 | 2016 | 294 | 0.030 |
Why?
|
| Antibodies, Antinuclear | 1 | 1995 | 342 | 0.030 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2001 | 782 | 0.030 |
Why?
|
| Electrophysiology | 2 | 2002 | 1263 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 20120 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 1996 | 393 | 0.030 |
Why?
|
| Centrifugation | 1 | 1993 | 122 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 484 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2022 | 6390 | 0.030 |
Why?
|
| Teaching | 1 | 2021 | 1169 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2014 | 314 | 0.030 |
Why?
|
| Protein Binding | 2 | 2003 | 9300 | 0.030 |
Why?
|
| Kidney Concentrating Ability | 1 | 1993 | 34 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 2057 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2003 | 1937 | 0.030 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 1993 | 36 | 0.030 |
Why?
|
| Acids | 1 | 1994 | 124 | 0.030 |
Why?
|
| Rubidium | 2 | 1989 | 121 | 0.030 |
Why?
|
| Electrolytes | 1 | 1994 | 274 | 0.030 |
Why?
|
| Desmin | 1 | 2012 | 99 | 0.030 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 1993 | 106 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4565 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2014 | 555 | 0.030 |
Why?
|
| Cattle | 3 | 2007 | 3819 | 0.030 |
Why?
|
| Wakefulness | 1 | 2019 | 1264 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 1999 | 1027 | 0.030 |
Why?
|
| Peptide Mapping | 1 | 1992 | 259 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1997 | 1963 | 0.030 |
Why?
|
| Scattering, Radiation | 2 | 2009 | 490 | 0.030 |
Why?
|
| Crystallization | 2 | 2009 | 528 | 0.030 |
Why?
|
| Aged | 6 | 2017 | 169266 | 0.020 |
Why?
|
| Gene Expression | 2 | 2009 | 7567 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2012 | 183 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1999 | 1333 | 0.020 |
Why?
|
| Connexin 43 | 1 | 2012 | 200 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 1376 | 0.020 |
Why?
|
| Tryptases | 1 | 2012 | 176 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 1999 | 1662 | 0.020 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2012 | 91 | 0.020 |
Why?
|
| Aquaglyceroporins | 1 | 2011 | 3 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2017 | 2666 | 0.020 |
Why?
|
| Neurofibromin 2 | 1 | 2012 | 269 | 0.020 |
Why?
|
| Infant | 3 | 2000 | 36164 | 0.020 |
Why?
|
| Chloride Channels | 1 | 2012 | 221 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1994 | 1429 | 0.020 |
Why?
|
| Hemoglobins | 1 | 1997 | 1525 | 0.020 |
Why?
|
| Ethylmaleimide | 1 | 1990 | 69 | 0.020 |
Why?
|
| Vasotocin | 1 | 1990 | 10 | 0.020 |
Why?
|
| HEPES | 1 | 1990 | 10 | 0.020 |
Why?
|
| 4-Chloromercuribenzenesulfonate | 1 | 1990 | 7 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2016 | 1173 | 0.020 |
Why?
|
| Neutron Diffraction | 1 | 2010 | 10 | 0.020 |
Why?
|
| Fetal Blood | 2 | 1994 | 1347 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1822 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 2002 | 1463 | 0.020 |
Why?
|
| Receptors, Bradykinin | 1 | 1990 | 19 | 0.020 |
Why?
|
| Acclimatization | 1 | 2011 | 113 | 0.020 |
Why?
|
| Mentors | 1 | 2016 | 663 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 655 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1996 | 1594 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2009 | 64670 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 2001 | 826 | 0.020 |
Why?
|
| Archaeoglobus fulgidus | 1 | 2009 | 6 | 0.020 |
Why?
|
| Health Status | 1 | 2003 | 4077 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1990 | 174 | 0.020 |
Why?
|
| Outpatients | 1 | 1998 | 1596 | 0.020 |
Why?
|
| Bradykinin | 1 | 1990 | 205 | 0.020 |
Why?
|
| Absorption | 1 | 1990 | 242 | 0.020 |
Why?
|
| Membranes | 1 | 1990 | 164 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 1067 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1999 | 1830 | 0.020 |
Why?
|
| Diuresis | 1 | 1990 | 106 | 0.020 |
Why?
|
| Malpighian Tubules | 2 | 2005 | 8 | 0.020 |
Why?
|
| Insect Proteins | 1 | 2011 | 254 | 0.020 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 2009 | 41 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1505 | 0.020 |
Why?
|
| Mesoderm | 1 | 2012 | 673 | 0.020 |
Why?
|
| Axons | 1 | 2017 | 1671 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2010 | 418 | 0.020 |
Why?
|
| Phloretin | 1 | 2009 | 16 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 3197 | 0.020 |
Why?
|
| Apoptosis | 2 | 2002 | 9478 | 0.020 |
Why?
|
| Larva | 1 | 2011 | 508 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 1989 | 167 | 0.020 |
Why?
|
| Nickel | 1 | 2009 | 126 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 799 | 0.020 |
Why?
|
| NAD | 1 | 1993 | 611 | 0.020 |
Why?
|
| Blood Donors | 1 | 2011 | 345 | 0.020 |
Why?
|
| Acidosis, Respiratory | 1 | 1988 | 37 | 0.020 |
Why?
|
| Adult | 6 | 2020 | 221083 | 0.020 |
Why?
|
| Alkalosis | 1 | 1988 | 55 | 0.020 |
Why?
|
| Sodium Chloride | 2 | 2006 | 584 | 0.020 |
Why?
|
| ABO Blood-Group System | 1 | 2011 | 381 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2016 | 1807 | 0.020 |
Why?
|
| Metals, Heavy | 1 | 2009 | 148 | 0.020 |
Why?
|
| Esters | 1 | 2009 | 210 | 0.020 |
Why?
|
| Extracellular Space | 2 | 1990 | 563 | 0.020 |
Why?
|
| Risk | 1 | 2000 | 9614 | 0.020 |
Why?
|
| Microvilli | 1 | 1988 | 234 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 1935 | 0.020 |
Why?
|
| Low Back Pain | 1 | 2016 | 983 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1992 | 1498 | 0.020 |
Why?
|
| Hospitalization | 2 | 2014 | 10712 | 0.020 |
Why?
|
| Motor Activity | 1 | 2017 | 2712 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1987 | 100 | 0.020 |
Why?
|
| Leadership | 1 | 2017 | 1386 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 888 | 0.020 |
Why?
|
| Phospholipids | 2 | 2006 | 784 | 0.020 |
Why?
|
| Electric Impedance | 2 | 2003 | 756 | 0.020 |
Why?
|
| Fetus | 1 | 1994 | 1862 | 0.020 |
Why?
|
| Age Factors | 2 | 2002 | 18385 | 0.020 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2016 | 1171 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 3725 | 0.020 |
Why?
|
| Copper | 1 | 2009 | 365 | 0.020 |
Why?
|
| Nitroprusside | 1 | 1987 | 272 | 0.020 |
Why?
|
| Pregnancy | 3 | 2019 | 29872 | 0.020 |
Why?
|
| Halobacterium salinarum | 1 | 2006 | 4 | 0.020 |
Why?
|
| Inpatients | 1 | 1998 | 2545 | 0.020 |
Why?
|
| Amino Acids | 1 | 1992 | 1703 | 0.020 |
Why?
|
| Barium | 3 | 1992 | 62 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2014 | 1409 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 1994 | 5870 | 0.020 |
Why?
|
| Acidosis | 1 | 1988 | 268 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2000 | 42217 | 0.020 |
Why?
|
| Vesicular Transport Proteins | 2 | 1999 | 374 | 0.020 |
Why?
|
| Eating | 1 | 1993 | 1535 | 0.020 |
Why?
|
| Adolescent | 3 | 2017 | 88271 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2017 | 3057 | 0.020 |
Why?
|
| Acetic Acid | 1 | 1986 | 59 | 0.020 |
Why?
|
| Middle Aged | 7 | 2017 | 220835 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 4014 | 0.020 |
Why?
|
| Acetazolamide | 1 | 1986 | 96 | 0.020 |
Why?
|
| Electrodes | 1 | 2008 | 611 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 1994 | 1893 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 1986 | 201 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3951 | 0.020 |
Why?
|
| Gestational Age | 1 | 1994 | 3577 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2021 | 4642 | 0.020 |
Why?
|
| Stilbenes | 1 | 1986 | 155 | 0.020 |
Why?
|
| Calorimetry | 2 | 1996 | 129 | 0.020 |
Why?
|
| Child | 3 | 2000 | 80134 | 0.020 |
Why?
|
| Zinc | 1 | 2009 | 672 | 0.020 |
Why?
|
| Sugar Alcohols | 1 | 2004 | 18 | 0.020 |
Why?
|
| Glycolipids | 1 | 2006 | 206 | 0.020 |
Why?
|
| Cell Separation | 1 | 1990 | 1718 | 0.020 |
Why?
|
| X-Rays | 1 | 2006 | 308 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 1997 | 222 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10421 | 0.010 |
Why?
|
| Algorithms | 2 | 2009 | 14023 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9518 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2020 | 80673 | 0.010 |
Why?
|
| Acetates | 1 | 1986 | 319 | 0.010 |
Why?
|
| Phase Transition | 1 | 2004 | 71 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 2004 | 108 | 0.010 |
Why?
|
| Choline | 1 | 2006 | 515 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 2000 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2016 | 3923 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 15308 | 0.010 |
Why?
|
| Ganglionic Blockers | 1 | 2003 | 4 | 0.010 |
Why?
|
| Hexamethonium | 1 | 2003 | 17 | 0.010 |
Why?
|
| Cytoprotection | 1 | 2004 | 200 | 0.010 |
Why?
|
| Dextrans | 2 | 1997 | 574 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2004 | 543 | 0.010 |
Why?
|
| Communication | 1 | 2017 | 3852 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4250 | 0.010 |
Why?
|
| Ion Transport | 1 | 2003 | 320 | 0.010 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2002 | 73 | 0.010 |
Why?
|
| Capsaicin | 1 | 2003 | 232 | 0.010 |
Why?
|
| Phylogeny | 1 | 2009 | 2809 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1986 | 1417 | 0.010 |
Why?
|
| Quality of Life | 1 | 2003 | 13362 | 0.010 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 1990 | 1725 | 0.010 |
Why?
|
| Inovirus | 1 | 2000 | 11 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 1982 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10552 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1900 | 0.010 |
Why?
|
| Administration, Intravesical | 1 | 2001 | 91 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16947 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1994 | 11066 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 2741 | 0.010 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2000 | 135 | 0.010 |
Why?
|
| Homozygote | 2 | 1996 | 1775 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 2000 | 298 | 0.010 |
Why?
|
| Electric Conductivity | 2 | 1992 | 405 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 15845 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2007 | 3936 | 0.010 |
Why?
|
| Gadolinium | 1 | 2004 | 961 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 2 | 1993 | 495 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7400 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2004 | 2219 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2000 | 445 | 0.010 |
Why?
|
| Cats | 1 | 2000 | 974 | 0.010 |
Why?
|
| Liver | 1 | 1994 | 7513 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2000 | 1057 | 0.010 |
Why?
|
| Receptors, Calcitriol | 1 | 2001 | 360 | 0.010 |
Why?
|
| Aldosterone | 1 | 2003 | 869 | 0.010 |
Why?
|
| Pelvis | 1 | 2002 | 734 | 0.010 |
Why?
|
| Mutation | 3 | 2004 | 30006 | 0.010 |
Why?
|
| Young Adult | 2 | 2017 | 59199 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1998 | 26187 | 0.010 |
Why?
|
| Yeasts | 1 | 1999 | 279 | 0.010 |
Why?
|
| Opossums | 1 | 1997 | 104 | 0.010 |
Why?
|
| Keratins | 1 | 1999 | 498 | 0.010 |
Why?
|
| Cimetidine | 1 | 1997 | 76 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 2261 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1989 | 4421 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 7873 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 5413 | 0.010 |
Why?
|
| Prevalence | 1 | 2014 | 15717 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1997 | 452 | 0.010 |
Why?
|
| Glycodeoxycholic Acid | 1 | 1996 | 23 | 0.010 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 1997 | 167 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2002 | 1674 | 0.010 |
Why?
|
| Taurodeoxycholic Acid | 1 | 1996 | 13 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1987 | 4164 | 0.010 |
Why?
|
| Taurochenodeoxycholic Acid | 1 | 1996 | 35 | 0.010 |
Why?
|
| Erythrocyte Aging | 1 | 1996 | 53 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 54419 | 0.010 |
Why?
|
| Micelles | 1 | 1996 | 192 | 0.010 |
Why?
|
| Pentagastrin | 1 | 1974 | 17 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1999 | 908 | 0.010 |
Why?
|
| Butanones | 1 | 1974 | 23 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1974 | 306 | 0.010 |
Why?
|
| Thiourea | 1 | 1974 | 68 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1999 | 1227 | 0.010 |
Why?
|
| Leucyl Aminopeptidase | 1 | 1994 | 12 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 1974 | 157 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1974 | 304 | 0.010 |
Why?
|
| Aging | 1 | 1993 | 8701 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1974 | 343 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 1994 | 8 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 58946 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1996 | 328 | 0.010 |
Why?
|
| Histidine | 1 | 1974 | 303 | 0.010 |
Why?
|
| Sulfides | 1 | 1974 | 168 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2007 | 6225 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1993 | 168 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74219 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1974 | 561 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 1993 | 112 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 29672 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 4451 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1988 | 9317 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3700 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6123 | 0.010 |
Why?
|
| Histamine | 1 | 1974 | 499 | 0.010 |
Why?
|
| Indicator Dilution Techniques | 1 | 1992 | 43 | 0.010 |
Why?
|
| Buffers | 1 | 1992 | 143 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 1993 | 271 | 0.010 |
Why?
|
| Serine | 1 | 1996 | 826 | 0.010 |
Why?
|
| Lactoperoxidase | 1 | 1991 | 5 | 0.010 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 1991 | 65 | 0.010 |
Why?
|
| Anura | 1 | 1991 | 80 | 0.010 |
Why?
|
| Creatinine | 1 | 1997 | 1897 | 0.010 |
Why?
|
| Succinimides | 1 | 1991 | 81 | 0.010 |
Why?
|
| Viscosity | 1 | 1992 | 335 | 0.010 |
Why?
|
| Immune Sera | 1 | 1991 | 605 | 0.010 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 1990 | 22 | 0.010 |
Why?
|
| Membrane Fusion | 1 | 1992 | 265 | 0.010 |
Why?
|
| Suspensions | 1 | 1990 | 66 | 0.010 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 1990 | 30 | 0.010 |
Why?
|
| Light | 1 | 1996 | 1351 | 0.010 |
Why?
|
| Particle Size | 1 | 1994 | 1649 | 0.010 |
Why?
|
| Arginine Vasopressin | 1 | 1990 | 125 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 8639 | 0.010 |
Why?
|
| Food | 1 | 1974 | 768 | 0.010 |
Why?
|
| Iodoacetic Acid | 1 | 1989 | 11 | 0.010 |
Why?
|
| Iodoacetates | 1 | 1989 | 17 | 0.010 |
Why?
|
| Digitonin | 1 | 1989 | 25 | 0.010 |
Why?
|
| Methylglucosides | 1 | 1989 | 35 | 0.010 |
Why?
|
| 3-O-Methylglucose | 1 | 1989 | 37 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1990 | 422 | 0.010 |
Why?
|
| Exons | 1 | 1994 | 2380 | 0.000 |
Why?
|
| Imidazoles | 1 | 1974 | 1173 | 0.000 |
Why?
|
| Culture Media | 1 | 1990 | 894 | 0.000 |
Why?
|
| Pedigree | 1 | 1996 | 4537 | 0.000 |
Why?
|
| Cytological Techniques | 1 | 1989 | 218 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1999 | 5775 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 4240 | 0.000 |
Why?
|
| Phosphoproteins | 1 | 1996 | 2443 | 0.000 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1989 | 684 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1991 | 1187 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1994 | 6067 | 0.000 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1990 | 1488 | 0.000 |
Why?
|
| Base Sequence | 1 | 1994 | 12404 | 0.000 |
Why?
|
| Oxygen | 1 | 1993 | 4226 | 0.000 |
Why?
|
| Glucose | 1 | 1989 | 4341 | 0.000 |
Why?
|